Previous research on endometrial carcinoma found that most MSI‐H tumors had loss of MLH1 and PMS2, with concordant loss of the MLH1/PMS2 heterodimer in 48% and with MSI‐H in 97% of PSM2‐negative cases 25. This evidence concerns the gene MLH1 and endometrial carcinoma.